217 related articles for article (PubMed ID: 16287144)
1. The frequency of mucolipidosis type IV in the Ashkenazi Jewish population and the identification of 3 novel MCOLN1 mutations.
Bach G; Webb MB; Bargal R; Zeigler M; Ekstein J
Hum Mutat; 2005 Dec; 26(6):591. PubMed ID: 16287144
[TBL] [Abstract][Full Text] [Related]
2. Mucolipidosis type IV: novel MCOLN1 mutations in Jewish and non-Jewish patients and the frequency of the disease in the Ashkenazi Jewish population.
Bargal R; Avidan N; Olender T; Ben Asher E; Zeigler M; Raas-Rothschild A; Frumkin A; Ben-Yoseph O; Friedlender Y; Lancet D; Bach G
Hum Mutat; 2001 May; 17(5):397-402. PubMed ID: 11317355
[TBL] [Abstract][Full Text] [Related]
3. Mucolipidosis type IV.
Bach G
Mol Genet Metab; 2001 Jul; 73(3):197-203. PubMed ID: 11461186
[TBL] [Abstract][Full Text] [Related]
4. Carrier screening for mucolipidosis type IV in the American Ashkenazi Jewish population.
Edelmann L; Dong J; Desnick RJ; Kornreich R
Am J Hum Genet; 2002 Apr; 70(4):1023-7. PubMed ID: 11845410
[TBL] [Abstract][Full Text] [Related]
5. Mucolipidosis type IV a rare genetic disorder: new addition to the Ashkenazi Jewish panel.
Gordon RM; Marchese T
J Midwifery Womens Health; 2004; 49(4):359-60. PubMed ID: 15236718
[TBL] [Abstract][Full Text] [Related]
6. Mucolipidosis type IV: the origin of the disease in the Ashkenazi Jewish population.
Raas-Rothschild A; Bargal R; DellaPergola S; Zeigler M; Bach G
Eur J Hum Genet; 1999; 7(4):496-8. PubMed ID: 10352940
[TBL] [Abstract][Full Text] [Related]
7. A physical and transcript map of the MCOLN1 gene region on human chromosome 19p13.3-p13.2.
Acierno JS; Kennedy JC; Falardeau JL; Leyne M; Bromley MC; Colman MW; Sun M; Bove C; Ashworth LK; Chadwick LH; Schiripo T; Ma S; Goldin E; Schiffmann R; Slaugenhaupt SA
Genomics; 2001 Apr; 73(2):203-10. PubMed ID: 11318610
[TBL] [Abstract][Full Text] [Related]
8. Identification of the gene causing mucolipidosis type IV.
Bargal R; Avidan N; Ben-Asher E; Olender Z; Zeigler M; Frumkin A; Raas-Rothschild A; Glusman G; Lancet D; Bach G
Nat Genet; 2000 Sep; 26(1):118-23. PubMed ID: 10973263
[TBL] [Abstract][Full Text] [Related]
9. Mucolipidosis type IV in a Turkish boy associated with a novel MCOLN1 mutation.
Tüysüz B; Goldin E; Metin B; Korkmaz B; Yalçinkaya C
Brain Dev; 2009 Oct; 31(9):702-5. PubMed ID: 19006653
[TBL] [Abstract][Full Text] [Related]
10. Rapid detection of the two common mutations in Ashkenazi Jewish patients with mucolipidosis type IV.
Wang ZH; Zeng B; Pastores GM; Raksadawan N; Ong E; Kolodny EH
Genet Test; 2001; 5(2):87-92. PubMed ID: 11551108
[TBL] [Abstract][Full Text] [Related]
11. Carrier frequency of autosomal-recessive disorders in the Ashkenazi Jewish population: should the rationale for mutation choice for screening be reevaluated?
Fares F; Badarneh K; Abosaleh M; Harari-Shaham A; Diukman R; David M
Prenat Diagn; 2008 Mar; 28(3):236-41. PubMed ID: 18264947
[TBL] [Abstract][Full Text] [Related]
12. Transfer of a mitochondrial DNA fragment to MCOLN1 causes an inherited case of mucolipidosis IV.
Goldin E; Stahl S; Cooney AM; Kaneski CR; Gupta S; Brady RO; Ellis JR; Schiffmann R
Hum Mutat; 2004 Dec; 24(6):460-5. PubMed ID: 15523648
[TBL] [Abstract][Full Text] [Related]
13. Familial dysautonomia and the expansion of the Ashkenazi Jewish carrier screening panel.
Gilbert F
Genet Test; 2001; 5(2):83-5. PubMed ID: 11551107
[No Abstract] [Full Text] [Related]
14. Mucolipidosis IV: novel mutation and diverse ultrastructural spectrum in the skin.
Bargal R; Goebel HH; Latta E; Bach G
Neuropediatrics; 2002 Aug; 33(4):199-202. PubMed ID: 12368990
[TBL] [Abstract][Full Text] [Related]
15. A founder mutation in the MPL gene causes congenital amegakaryocytic thrombocytopenia (CAMT) in the Ashkenazi Jewish population.
Jalas C; Anderson SL; Laufer T; Martimucci K; Bulanov A; Xie X; Ekstein J; Rubin BY
Blood Cells Mol Dis; 2011 Jun; 47(1):79-83. PubMed ID: 21489838
[TBL] [Abstract][Full Text] [Related]
16. When Mucolipidosis III meets Mucolipidosis II: GNPTA gene mutations in 24 patients.
Bargal R; Zeigler M; Abu-Libdeh B; Zuri V; Mandel H; Ben Neriah Z; Stewart F; Elcioglu N; Hindi T; Le Merrer M; Bach G; Raas-Rothschild A
Mol Genet Metab; 2006 Aug; 88(4):359-63. PubMed ID: 16630736
[TBL] [Abstract][Full Text] [Related]
17. The molecular basis of mucolipidosis type IV.
Slaugenhaupt SA
Curr Mol Med; 2002 Aug; 2(5):445-50. PubMed ID: 12125810
[TBL] [Abstract][Full Text] [Related]
18. Bloom syndrome and Fanconi's anemia: rate and ethnic origin of mutation carriers in Israel.
Peleg L; Pesso R; Goldman B; Dotan K; Omer M; Friedman E; Berkenstadt M; Reznik-Wolf H; Barkai G
Isr Med Assoc J; 2002 Feb; 4(2):95-7. PubMed ID: 11876000
[TBL] [Abstract][Full Text] [Related]
19. The Ashkenazi Jewish Fanconi anemia mutation: incidence among patients and carrier frequency in the at-risk population.
Whitney MA; Jakobs P; Kaback M; Moses RE; Grompe M
Hum Mutat; 1994; 3(4):339-41. PubMed ID: 8081385
[TBL] [Abstract][Full Text] [Related]
20. Mucolipidosis type IV and the mucolipins.
Bach G; Zeevi DA; Frumkin A; Kogot-Levin A
Biochem Soc Trans; 2010 Dec; 38(6):1432-5. PubMed ID: 21118102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
